An adjuvant strategy enabled by modulation of the physical properties of fungal mannans elicits pan-coronavirus reactive anti-SARS-CoV-2 Spike antibodies

• Published in: The Journal of Immunology Vol. 206; no. 1_Supplement; p. 30.08
• Main Authors: Borriello, Francesco, Spreafico, Roberto, Poli, Valentina, Shrock, Ellen, Chou, Janet, Barrett, Nora A, Lacanfora, Lucrezia, Franco, Marcella E, Marongiu, Laura, Iwakura, Yoichiro, Pucci, Ferdinando, Kruppa, Michael D, Ma, Zuchao, Lowman, Douglas W, Ensley, Harry E, Nanishi, Etsuro, Saito, Yoshine, O’Meara, Timothy R, Seo, Hyuk-Soo, McGrath, Marisa E, Logue, James, Haupt, Robert E, Dhe-Paganon, Sirano, Dowling, David J, Frieman, Matthew, Elledge, Stephen J, Levy, Ofer, Irvine, Darrell J, Williams, David L, Zanoni, Ivan
• Format: Journal Article
• Language: English; Japanese
• Published: The American Association of Immunologists 01.05.2021
• ISSN: 0022-1767; 1550-6606
• DOI: 10.4049/jimmunol.206.supp.30.08

Activation of the innate immune system via pattern recognition receptors (PRRs) is key to generate long-lasting adaptive immunity. While it is known that PRRs detect unique chemical patterns associated with invading microorganism, if and how the physical properties of PRR ligands influence development of the immune response is largely overlooked. Through the study of fungal mannans we present data that put the physical form of PRR ligands at the center of the process that determines the outcome of the immune response. Soluble mannans are immunosilent in the periphery but elicit a potent pro-inflammatory response in the draining lymph node (dLN). By modulating the physical form of mannans, we developed a formulation that targets both periphery and dLN. When combined with SARS-CoV-2 Spike, this formulation elicits neutralizing anti-SARS-CoV-2 antibodies that cross-react with pathogenic coronaviruses. Thus, the physical properties of fungal ligands can be harnessed for rational adjuvant design and vaccine development.